These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 28130595)
1. The comparative efficacy and safety of topical non-steroidal anti-inflammatory drugs for the treatment of anterior chamber inflammation after cataract surgery: a systematic review and network meta-analysis. Duan P; Liu Y; Li J Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):639-649. PubMed ID: 28130595 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and patients' tolerability of Nepafenac and Ketorolac in the treatment of ocular inflammation following cataract surgery: A meta-analysis of randomized controlled trials. Zhao X; Xia S; Wang E; Chen Y PLoS One; 2017; 12(3):e0173254. PubMed ID: 28253334 [TBL] [Abstract][Full Text] [Related]
3. The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery. Jung JW; Chung BH; Kim EK; Seo KY; Kim TI Yonsei Med J; 2015 Nov; 56(6):1671-7. PubMed ID: 26446653 [TBL] [Abstract][Full Text] [Related]
4. Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac. Lindstrom R; Kim T Curr Med Res Opin; 2006 Feb; 22(2):397-404. PubMed ID: 16466612 [TBL] [Abstract][Full Text] [Related]
5. Topical nonsteroidal anti-inflammatory drugs as adjuvant therapy in the prevention of macular edema after cataract surgery. Cardascia N; Palmisano C; Centoducati T; Alessio G Int Ophthalmol; 2017 Oct; 37(5):1127-1131. PubMed ID: 27766540 [TBL] [Abstract][Full Text] [Related]
6. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification. Sahu S; Ram J; Bansal R; Pandav SS; Gupta A J Cataract Refract Surg; 2015 Oct; 41(10):2043-8. PubMed ID: 26703278 [TBL] [Abstract][Full Text] [Related]
7. Nepafenac: an ophthalmic nonsteroidal antiinflammatory drug for pain after cataract surgery. Jones BM; Neville MW Ann Pharmacother; 2013 Jun; 47(6):892-6. PubMed ID: 23715071 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery. Rossetti L; Bujtar E; Castoldi D; Torrazza C; Orzalesi N J Cataract Refract Surg; 1996; 22 Suppl 1():794-9. PubMed ID: 9279674 [TBL] [Abstract][Full Text] [Related]
9. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Miyanaga M; Miyai T; Nejima R; Maruyama Y; Miyata K; Kato S Acta Ophthalmol; 2009 May; 87(3):300-5. PubMed ID: 19183412 [TBL] [Abstract][Full Text] [Related]
10. Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. Kessel L; Tendal B; Jørgensen KJ; Erngaard D; Flesner P; Andresen JL; Hjortdal J Ophthalmology; 2014 Oct; 121(10):1915-24. PubMed ID: 24935281 [TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Retinal Diseases. Rodrigues EB; Farah ME; Bottós JM; Bom Aggio F Dev Ophthalmol; 2016; 55():212-20. PubMed ID: 26502088 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery. Li SS; Wang HH; Wang YL; Zhang DW; Chen X Int Ophthalmol; 2023 Jan; 43(1):271-284. PubMed ID: 36065039 [TBL] [Abstract][Full Text] [Related]
13. Topical diclofenac sodium for treatment of postoperative inflammation in cataract surgery. Reddy MS; Suneetha N; Thomas RK; Battu RR Indian J Ophthalmol; 2000 Sep; 48(3):223-6. PubMed ID: 11217255 [TBL] [Abstract][Full Text] [Related]
14. Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent. Jones J; Francis P Expert Opin Pharmacother; 2009 Oct; 10(14):2379-85. PubMed ID: 19735215 [TBL] [Abstract][Full Text] [Related]
15. Comparing the Efficacy of Ophthalmic NSAIDs in Common Indications: A Literature Review to Support Cost-effective Prescribing. Wilson DJ; Schutte SM; Abel SR Ann Pharmacother; 2015 Jun; 49(6):727-34. PubMed ID: 25725037 [TBL] [Abstract][Full Text] [Related]
16. The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery. Giannaccare G; Finzi A; Sebastiani S; Greco F; Versura P; Campos EC Curr Eye Res; 2018 Dec; 43(12):1445-1453. PubMed ID: 30009640 [TBL] [Abstract][Full Text] [Related]
17. Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1. Coassin M; De Maria M; Mastrofilippo V; Braglia L; Cimino L; Sartori A; Fontana L Adv Ther; 2019 Oct; 36(10):2712-2722. PubMed ID: 31482510 [TBL] [Abstract][Full Text] [Related]
18. A comparative analysis of topical corticosteroids and non-steroidal anti-inflammatory drugs to control inflammation and macular edema following uneventful phacoemulsification. Singhal D; Nanda A; Kanungo S; Sahoo K; Mohapatra S Indian J Ophthalmol; 2022 Feb; 70(2):425-433. PubMed ID: 35086209 [TBL] [Abstract][Full Text] [Related]
19. Use of topical bromfenac for treating ocular pain and inflammation beyond cataract surgery: a review of published studies. Schechter BA Clin Ophthalmol; 2019; 13():1439-1460. PubMed ID: 31534309 [TBL] [Abstract][Full Text] [Related]